ALK and Histiocytosis: ALK-positive histiocytosis, which shows a broad clinicopathologic spectrum unified by the presence of ALK gene translocation (most commonly KIF5B::ALK) and remarkable response to ALK-inhibitor therapy, has been better characterized in recent studies [88, 96].